Jonathan D Sorah

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 05, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.

Hanna K Sanoff, Allison M Deal, Jai Patel

|Jun 03, 2024
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.

Jonathan D Sorah, Allison M Deal, Sophia I Stein

|Oct 26, 2022
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.

Jonathan D Sorah, Dominic T Moore, Matthew J Reilley

|Sep 18, 2021
Brief Report: Improving Fellow Performance of the Pharmacology Section of the American Society of Clinical Oncology In-Training Exam.

Jonathan D Sorah, Sean Clark-Garvey, Frances A Collichio

Pageof 1

Frequent Collaborators

2 joint publications

Allison M Deal

2 joint publications

Ethan M Basch

2 joint publications

Hanna K Sanoff

1 joint publications

Jacquelyne Gaddy